Lilly’s $1.8 Billion Biologics Expansion Expected to Grow Manufacturing Footprint in Ireland

Pharmaceutical Processing World

Lilly expands manufacturing footprint in Ireland

Eli Lilly and Co. recently announced that it’s spending $1 billion to expand its Limerick, Ireland, manufacturing site. The goal of the expansion, announced Sept. 12, is to increase the production of biologic active ingredients, including those for the company’s recently approved treatment for early symptomatic Alzheimer’s disease. The company announced in July that the FDA has approved Kisunla (donanemab-azbt, 350 mg/20 mL once-monthly injectio…